Viemed Healthcare (FRA:VIJ) Interest Expense: €-1.1 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VIJ Viemed Healthcare Inc FRA:VIJ
93 GF Score
Price €10.30
GF Value €9.43
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Viemed Healthcare Interest Expense?

Viemed Healthcare FRA:VIJ +0.98% 93 Interest Expense is €-1.1 Mil as of Mar. 2026. GuruFocus rates FRA:VIJ with a GF Score™ of 93/100 and a GF Value™ of €9.43 (Fairly Valued). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Viemed Healthcare's interest expense for the three months ended in Mar. 2026 was € -0.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-1.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Viemed Healthcare's Operating Income for the three months ended in Mar. 2026 was € 4.0 Mil. Viemed Healthcare's Interest Expense for the three months ended in Mar. 2026 was € -0.3 Mil. Viemed Healthcare's Interest Coverage for the quarter that ended in Mar. 2026 was 15.24. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Viemed Healthcare  (FRA:VIJ) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Viemed Healthcare's Interest Expense for the three months ended in Mar. 2026 was €-0.3 Mil. Its Operating Income for the three months ended in Mar. 2026 was €4.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €9.0 Mil.

Viemed Healthcare's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*4.024/-0.264
=15.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Viemed Healthcare Interest Expense Historical Data

* Premium members only.

The historical data trend for Viemed Healthcare's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viemed Healthcare Interest Expense Chart

Viemed Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.28 -0.19 -0.39 -0.74 -1.01

Viemed Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.11 -0.43 -0.31 -0.26
FRA:VIJ
93GF Score
Viemed Healthcare Inc FRA:VIJ
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viemed Healthcare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-1.1 Mil mean?
Viemed Healthcare (FRA:VIJ) has a Interest Expense of €-1.1 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Viemed Healthcare and its competitors.
Is Viemed Healthcare's Interest Expense too high?
Viemed Healthcare's current Interest Expense is €-1.1 Mil. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Interest Expense compare to DCTH and VREX?
Viemed Healthcare's Interest Expense of €-1.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Viemed Healthcare and its competitors. Viemed Healthcare's current Interest Expense is €-1.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (FRA:VIJ) is currently considered Fairly Valued. The stock's GF Value™ is €9.43, compared to a current price of €10.30 — trading 9.2% above its estimated fair value. The current Interest Expense is €-1.1 Mil. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Viemed Healthcare (FRA:VIJ), the current Interest Expense is €-1.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viemed Healthcare (FRA:VIJ) Overvalued in 2026?

Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued. The current stock price of €10.30 is trading 9.2% above its estimated GF Value™ of €9.43. GuruFocus considers Viemed Healthcare to be Fairly Valued.

Key valuation signals for FRA:VIJ:

  • Interest Expense: €-1.1 Mil
  • GF Value™: €9.43 vs. price of €10.30 (9.2% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the FRA:VIJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viemed Healthcare Business Description

Other Exchanges VMD:USA
Address 625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score

Get the complete analysis for FRA:VIJ

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.30
Price
€9.43
GF Value